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Nef Triggers a Transcriptional Program in T Cells
Imitating Single-Signal T Cell Activation
and Inducing HIV Virulence Mediators
the transcripts appearing immediately postintegration
(Klotman et al., 1991). It is therefore likely to influence
viral replication at a period before Tat and Rev act. A
possible role for Nef may be to induce a state of activa-
tion in the host T cell. HIV replicates to high levels after
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T cells have been activated by a variety of exogenousHeadington
stimuli. In part, this is due to the close similarity betweenOxford OX3 9DS
the HIV transcriptional regulatory elements and those2 The Wellcome Trust Immunology Unit
of many inducible T cell genes. There is a growing bodyMRC Building
of evidence to support such a role for Nef in virulenceAddenbrookes Hospital Site
enhancement. Thymocytes of transgenics expressingHills Road
Nef under control of the CD4 promoter/enhancer exhibitCambridge CB2 2QH
constitutive tyrosine phosphorylation of LAT and p42/United Kingdom
44 MAP kinase and anti-CD3 hyperreactivity (Hanna et
al., 1998). NFAT activity is increased in a highly patho-
genic strain of SIV, SIVmac239, containing a Nef variantSummary
with a functional immunoreceptor tyrosine-based acti-
vation motif (ITAM) (Luo and Peterlin, 1997). Nef chime-Gene expression profiling was used to explore the role
ras expressed in Jurkat can induce T cell activation orof Nef in HIV. Nef induces a transcriptional program
inhibition, depending on whether they are localized atin T cells that is 97% identical to that of anti-CD3 T cell
the cell surface or intracellularly (Baur et al., 1994). Re-activation. This program is inhibited in the presence of
cently, it has been shown that Nef is present in lipid raftscyclosporin. A requirement for TCR and ZAP-70 is
and is associated with an increased level of tyrosine-demonstrated for formation of the complete profile.
phosphorylated T cell signaling moieties in rafts. ThisAmong eight factors particular to the anti-CD3 activa-
raft association is required for Nef-mediated hyperin-tion profile are IL16 and YY1, negative regulators of HIV
duction of NF-B, NFAT, IL-2, and HIV-1 long terminaltranscription. In contrast, Nef exclusively upregulates
repeat (LTR) reporters following stimulation throughfactors positively regulating HIV, including Tat-SF1,
CD3 and CD28 (Wang et al., 2000).U1 SNRNP, and IRF-2. New genes associated with Nef
Much of the previous work investigating the mecha-include CDK9, the induction of which enhances Tat
nism by which Nef might activate T cells has focusedfunction. Thus, Nef acts as a master switch early in
on delineating Nef protein-protein interactions. Nef is athe viral life cycle, forcing an environment conducive
modular protein containing a myristoylated N terminus,to dynamic viral production.
a core domain, and a polyproline motif. The polyproline
motif acts as an SH3 binding domain that is highly con-Introduction
served between viral isolates. This domain is capable
of mediating associations between Src kinases (SakselaNef is known to enhance pathogenicity in human immu-
et al., 1995), and, in the case of Hck and Lck, this altersnodeficiency virus (HIV) and simian immunodeficiency
the catalytic activity of the enzyme (Briggs et al., 1997;virus (SIV). Nef-defective viruses lead to an attenuated
Baur et al., 1997). It also facilitates Nef binding to Vavclinical phenotype with reduced viral loads in mouse
and Vav2, which results in cytoskeletal changes and
models, monkeys, and in human disease (Deacon et al.,
activation of the JNK cascade (Fackler et al., 1999).
1995; Gulizia et al., 1997; Kestler et al., 1991). Multiple
Both HIV and SIV Nef can be coimmunoprecipitated with
cellular functions have been attributed to this protein, TCR (Howe et al., 1998; Xu et al., 1999). In the case of
diverging from its ability to act as an adaptor to the host HIV Nef, the polyproline motif has been shown to regu-
cell signaling or vesicular trafficking machinery. Apart late this interaction (Xu et al., 1999). The core domain
from the well-known effects of CD4 downregulation fa- of Nef contains a diarginine motif that allows a functional
cilitating enhanced virion release (Aiken et al., 1994; interaction with PAK kinase associated with increased
Lama et al., 1999; Ross et al., 1999), Nef downregulates viral infectivity (Fackler et al., 2000; Renkema et al.,
MHC class I (Collins et al., 1998; Schwartz et al., 1996) 1999). Other signaling proteins reported to associate
and upregulates fasL (Xu et al., 1997), providing a possi- with Nef include c-Raf1 (Hodge et al., 1998) and protein
ble role in evasion of the immune response to HIV. Nef kinase C (Smith et al., 1996).
increases the efficiency of viral replication and enhances Data generated in this way indicate what is function-
virion infectivity (Aiken and Trono, 1995; Chowers et al., ally possible but may not necessarily reflect the function
1995; Miller et al., 1994) in experimental systems, but of candidate proteins in intact cells. We elected to inves-
the exact molecular mechanism underlying this effect tigate Nef action in putative T cell activation and viru-
has not been fully delineated. lence induction by monitoring transcriptional changes
As an early expressed gene of HIV, Nef forms 80% of seen on large-scale gene expression profiling. We ex-
pressed Nef in a regulated fashion, using the tetracy-
cline-inducible system. Nef exerts a widespread tran-3 Correspondence: andrew.mcmichael@ndm.ox.ac.uk
4 These authors contributed equally to this work. scriptional program in T cells, escalating in breadth and
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intensity over time. Several of the genes affected were
recognizable as T cell activation-induced genes. We
compared the expression profile generated by Nef to
that occurring on T cell activation. Stimulation of Jurkat
with plate-bound anti-CD3 antibody resulted in a gene
expression match that was 97% identical to the Nef
response. We identify components of the T cell receptor
signaling pathway necessary for the Nef expression pro-
file and highlight differences between this and T cell
activation-induced gene expression that may contribute
to Nef activity.
Results
Inducible Expression of HIV-1 nef
Previous attempts at creating stable Nef T cell lines
have been hampered by the fact that prolonged nef
expression causes cell death (Baur et al., 1994). We
used the tetracycline system described by Bujard and
Gossen (Gossen et al., 1995) to obtain controlled expres-
sion of nef in Jurkat cells. Wild-type (WT) SF2 nef was
placed in a bicistronic arrangement with enhanced
green fluorescent protein (EGFP) as a marker of gene
induction. Western blot and FACS analysis showed
tightly regulated gene expression pre- and posttreat-
ment with doxycycline (Figures 1A and 1B). A control
cell line contained inducible EGFP alone. Growth of the
WT-EGFP cell line in doxycycline resulted in a decrease
in CD4 and MHC class I expression, consistent with
previous reports (Greenberg et al., 1998) (Figure 1C).
The Nef Expression Profile
We screened for differential changes in gene expression
occurring over time after induction of Nef in tetracycline-
inducible cell lines. As an early expressed HIV gene,
any host cell transcriptional changes exerted by Nef are
likely to have relevance for the viral life cycle at earlier
time points. Expression profiles at 18, 24, 30, and 36 hr
after doxycycline treatment were compared. As Nef is
Figure 1. Inducible Expression of WT neffirst detectable at 12 hr in the cell lines, this is represen-
(A) Western blot analysis of cell lines inducibly expressing WT-EGFPtative of 6, 12, 18, and 24 hr after Nef expression. Total
and control EGFP alone, showing induction of Nef at 12, 24, and 48RNA was used to make [32P]cDNA probes. Using Clon-
hr after addition of doxycycline at 1 g/ml (top panel). The mem-tech cDNA microarrays, 3528 genes were analyzed. Raw
branes are stripped and blotted for -actin (bottom panel).
intensity values were obtained from at least three repli- (B) FACS analysis of EGFP expression pre- and posttreatment of
cate experiments, using GenePix 3.0 software (Axon WT-EGFP and control cell lines with doxycycline, illustrating tightly
Instruments). Atlas Navigator software (Clontech/Sigen- regulated EGFP expression in Nef-positive and control cells.
(C) FACS dot plots after dual staining of noninduced and inducedetics) was used for subsequent normalization and clus-
populations with MHC class I PE and CD4 TRI.ter analysis. For full details of array analysis and statisti-
cal methods, see supplemental data at http://www.
immunity.com/cgi/content/full/14/6/763/DC1. Nef pro-
duces widespread differential gene expression in the T two nodes of upregulated transcripts. Cluster group A
contains genes whose expression is gradually inducedcell that escalates over time (Figure 2A). In contrast,
doxycycline treatment of control EGFP-expressing cell over the time course and whose expression peaks to-
ward later time points. Cluster group B contains geneslines resulted in no significant changes in gene induc-
tion. We focus the current analysis on upregulated whose expression achieves a plateau at earlier time
points. A relative overrepresentation of transcriptiongenes. We defined significantly upregulated genes as
exhibiting a normalized relative intensity ratio of 3 or factors, RNA processing genes, and genes directing
posttranslational modification is observed in clusterabove, with a raw intensity value of more than 150. For
a complete list of genes upregulated by Nef over 24 hr, group A. Cluster group B contains intracellular transduc-
ers, genes regulating protein turnover, and metabolicsee the supplemental data. K-tuple means clustering
(Eisen et al., 1998) was used to display the kinetics regulators. Genes on our arrays that were previously
demonstrated as induced by Nef included MIP-1 andof Nef-induced gene expression (Figure 2B). Using the
standard correlation coefficient, genes clustered into MIP-1 (Swingler et al., 1999), and these were upregu-
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lated as expected. A series of genes impacting on the Nef induces several paracrine effectors over 24 hr
viral life cycle are upregulated by Nef (Table 1). Strikingly, (Table 1; supplemental data); apart from MIP-1 and
fifteen transcription factors that activate the HIV-1 LTR MIP-1, two have been described as influencing the HIV
are induced. Cellular host proteins bind to a variety of life cycle. TGF- is increased in the supernatants of
cis-acting DNA sequences located within the LTR and HIV-infected peripheral blood mononuclear cell (PBMC)
tightly regulate HIV-1 proviral gene expression. Multiple cultures (Kekow et al., 1990) and is capable of stimulat-
regulatory regions are required for LTR transactivation. ing transcription from the LTR by activating NF-B (Li
Mutations in the SP1, TATA, TAR loop, and stem second- et al., 1998). IL-4 stimulates the expression of all HIV
ary structure severely disable the response of LTR re- isolates via a transcriptional activation mechanism (Va-
porters to exogenous activators. Nef induces ETS-1, lentin et al., 1998). Altogether, the expression profile
which acts cooperatively with NF-B and NFAT to medi- hints that Nef acts to further the viral life cycle by direct-
ate synergistic activation of the HIV-1 and HIV-2 en- ing the accessibility of multiple host CD4 T cell factors
hancers (Bassuk et al., 1997). ETS-1 also acts synergisti- via an intrinsic activation trigger.
cally with USF-1 at the HIV distal enhancer region of the
LTR (Sieweke et al., 1998). ATF-2 induces HIV transcrip- Nef Gene Expression Profile Closely Mimics
tion, and increased levels of ATF proteins and DNA bind- that of Anti-CD3 T Cell Activation
ing activity are observed in nuclear extracts of T cell Within the Nef expression profile, we noted induction of
lines infected with HIV (Rabbi et al., 1997). GAPB acti- 23 genes that are also upregulated on T cell activation
vates the LTR in a Raf1-responsive manner (Flory et al., (see supplemental data). Previous assessments of acti-
1996). IRF1 and IRF2 bind to the downstream binding vation of T cells by Nef have utilized readouts obtained
factor site in the HIV promoter to exert a positive effect from NF-B, NFAT, AP1, and IL-2 reporter constructs;
on viral replication (Van Lint et al., 1997). In addition, measurements of calcium flux; changes in tyrosine
IRF2 inhibits virus-induced interferon- (IFN-) tran- phosphorylation; or in vitro kinase assays assessing cat-
scription by preventing enhanceosome-dependent re- alytic activity of key T cell signaling molecules. While
cruitment of the CBP-Pol II holoenzyme complex (Senger giving insight to the effect of Nef on T cell activation
et al., 2000). Several of the HIV LTR transactivators Nef paths in specific experimental contexts, they do not
upregulates (NFATc, c-fos, JunD, IRF-1, c-myb, CIITA, provide a unifying picture as to the extent or specificity
and HIV-EP2) are inducibly expressed on T cell activa- of Nef T cell activation. Indeed, some studies have in-
tion (Chuvpila et al., 1999; Bosselut et al., 1992; Das- ferred an inhibitory effect of Nef on T cell signaling (Ban-
gupta et al., 1990; Kinoshita et al., 1997; Mercier et al., dres and Ratner, 1994; Collette et al., 1996; Greenway
1994; Saifuddin et al., 2000). et al., 1996; Iafrate et al., 1997). Large-scale gene ex-
It was interesting to observe upregulation of several pression profiling enables comparison of the Nef profile
host cell factors required for action of another viral ac- to reference activation states. We activated Jurkat with
cessory gene product, Tat. One of these, CDK9, is the plate-bound anti-CD3 and performed cDNA microarray
catalytic component of transcription elongation factor analysis at 12 and 24 hr. These profiles were compared
b (P-TEFb), which acts in concert with Tat to direct
to those obtained after Nef induction at 24 and 36 hr in
the processivity of HIV transcription (Zhu et al., 1997;
the tet cell lines (representative of 12 and 24 hr from
Mancebo et al., 1997). CDK9 mRNA and protein levels
when Nef is detectable). Remarkably, the activation of
are induced following T cell activation, and this corre-
Jurkat via this route revealed 97% identity (p  0.01) inlates with kinase activity (Herrmann et al., 1998). In addi-
upregulated transcripts with those of Nef (Figure 3 andtion to upregulating CDK9, Nef may prevent its degrada-
Supplemental Figure S1). In contrast, activation of Jur-tion by induction of heat shock protein 70 (Hsp 70).
kat via plate-bound anti-CD28 results in induction ofHsp70 serves as a chaperone that stabilizes CDK9 prior
145 genes over 24 hr, with 80% identity in induced genesto binding by a cyclin partner (O’Keeffe et al., 2000).
(Figure 3). For a full list of CD28-induced genes, seeHsp70 is known to be induced following HIV infection
the supplemental data. While T cell activation by TCRof CD4 T cell lines, and this induction is coincident with
triggering and Nef expression induce a number of sharedthe presence of singly and multiply spliced HIV-1 tran-
genes that promote the virus life cycle, some potentiallyscripts, declining on the emergence of full-length geno-
important differences were noted. Ten transcripts thatmic HIV-1 mRNA (Wainberg et al., 1997). Nef induces
are absent from the anti-CD3 activation profile areseveral other genes that positively regulate Tat. These
upregulated by Nef (Table 2). Three of these genes, TAT-include Tat-SF1, whose overexpression specifically
SF1, IRF2, and U1 SNRNP, are positive regulators ofstimulates transcriptional activity of Tat in vivo (Kim et
the viral life cycle. IRF2 prevents virus-induced IFN-al., 1999), TAR binding protein (TARBP), which acts in
gene transcription (Senger et al., 2000). Anti-CD3 activa-synergy with Tat to activate the LTR (Gatignol et al.,
tion resulted in upregulation of eight transcripts that are1996), and Pur , a single-strand DNA binding protein
absent from the Nef profile (Table 2). These include thethat binds TAR RNA and activates HIV transcription
transcription factor YY1, which represses HIV-1 LTR ac-(Chepenik et al., 1998). Nef also upregulates c-abl tyro-
tivity (Coull et al., 2000), and cytokine IL-16, which inhib-sine kinase, which phosphorylates the carboxy-terminal
its HIV growth in cell culture (Center et al., 2000). Thesedomain (CTD) of RNA polymerase II activating the HIV
differences hint that the mode of Nef T cell activationpromoter in the absence of Tat (Baskaran et al., 1999).
may be highly specific and geared toward a heightenedUpregulation of U1 SNRNP is observed. U1 SNRNP
replicative state for the virus, over and above a conven-maintains inactivity of the 5 LTR poly(A) site required
tional activation stimulus. We examined how this single-for the formation of mature HIV transcripts by interaction
with the major splice donor site (Ashe et al., 1997). signal T cell activation triggered by Nef might present
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Figure 2. Nef Induces a Transcriptional Program in T Cells
(A) Serial scatter profiles demonstrate gene expression over time after induction of Nef. Raw intensity values are plotted against control values
for each gene (see normalization methods in supplemental data). The green lines indicate the relative expression of the data sets relative to
time 0. The upper line marks a 2-fold increase, the lower line marks a 2-fold decrease, and the center line indicates equivalent expression.
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Table 1. Nef-Upregulated Genes Associated with HIV
Encoded Protein GenBank Accession Number Maximal Normalized Relative Intensity Ratio
Transcription Factors Positively Regulating the HIV-1 LTR
Pur- M96684 8.0
NFATc U08015 5.1
NF-B p100; p52 X61498 3.3
IRF-2 X15949 4.6
IRF-1 X14454 4.0
c-myb M15024 14.4
c-fos K00650 3.5
Jun-D X56681 3.2
ETS-1 J04101 4.0
ATF-2 L05515 3.4
CIITA X74301 4.1
HIV-EP2 M60119 4.6
GABP- D13316 4.4
TFIID 28 kD subunit X83928 7.9
Tat Facilitators Required for Processivity of Transcription
TAR binding protein M60801 3.0
RNA pol II (RPB 3) J05448 3.9
RNA pol II (RPB 2) X63563 4.8
RNA pol II (RPB 6) Z27113 3.1
CDK9 L25676 10.7
TAT-SF1 U76992 3.3
c-abl M14752 7.3
Formation of Full-Length Transcripts
U1 SNRNP A protein X06347 5.0
Nuclear Pore Transporter
NUP-98 U41815 15.6
Increased in HIV PBMC
70 kD HSP 1 M11717 4.8
Heat shock-related 70 kD protein 2 L26336 10.1
IL-6 receptor  subunit M57230 6.7
Paracrine Effectors
IL-4 precursor M13982 4.8
MIP-1 M23452 9.9
MIP-1 J04130 3.2
TGF X02812 3.4
Incorporation in Virions
ezrin X51521 4.1
an advantage to viral replication following subsequent feron-/ receptor, which does not occur in the pres-
ence of Nef. IL-3 precursor is induced exclusively in theexogenous activation. The expression profile of Jurkat
activated through CD3 and CD28 was compared to that presence of Nef. Genes induced after combined CD3/
CD28 stimulation of Nef-expressing cells are listed inof Nef-expressing Jurkat activated via this route. Genes
induced after CD3/CD28 activation are a combination the supplemental data.
of the transcripts induced after activation via either route
singly. The presence of Nef results in hyperinduction of Nef Expression Profile Is Attenuated in the Presence
of Cyclosporinseveral T cell-inducible genes, including IL-2 and
NFATc. In addition, the differences observed between It follows from the close identity between Nef and anti-
CD3 expression profiles that formation of the Nef tran-the anti-CD3 and Nef profiles are preserved (Table 2).
CD3/CD28 stimulation results in upregulation of inter- scriptome should occur via the same signaling and tran-
(B) K-tuple clustering was used to display the expression ratios of Nef-induced genes over time. Included in the cluster analysis were genes
that are upregulated more than 3 in normalized relative intensity ratio of signal to control. All measurements are relative to time 0. The color
scale ranges from saturated red for upregulated genes to saturated blue for downregulated genes, according to the key. A single row of
colored boxes represents each gene, and each column represents a single time point. Significantly induced (raw intensity more than 150)
functional groups of coregulated genes are indicated. This represents data obtained from Atlas Human 1.2 Array III (Array 1.2 III) (Clontech).
A full documentation of Nef-induced transcripts from all arrays used (Atlas Human 1.2, Atlas Human 1.2 Array II, and Atlas Human 1.2 Array
III) and their cluster classification can be found in the supplemental data.
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Figure 3. The Nef Expression Profile Compared with that of Anti-CD3 and Anti-CD28 T Cell Activation
The ordered list demonstrates the similarity in kinetics of gene induction between Nef- and anti-CD3-activated Jurkat in contrast to that of
anti-CD28-activated Jurkat. All genes from Array 1.2 III induced more than 3 in intensity ratio are included on the representation. Significantly
induced genes are listed alongside (i.e., genes induced more than 3, with a raw intensity value of more than 150; see supplemental data).
Arrays 1.2 and 1.2 II showed similar profile kinetics.
Nef Generates a Transcriptional Program in T Cells
769
Table 2. Differences between the Nef and Anti-CD3 Expression Profiles and How These Are Preserved after Exogenous Stimulation
Encoded Protein GenBank Accession Number Maximal Normalized Relative Intensity Ratio
Genes Upregulated by Nef but Not Anti-CD3
IRF2 X15949 4.6
TAT SF1 U76992 3.4
U1 SNRNP A X06347 5.0
-COP X70476 3.9
DP1 L23959 4.0
Pinch protein U09284 9.0
PLC 3 Z16411 4.0
Genes Upregulated by Anti-CD3 but Not Nef
IL-16 M90391 17.1
YY1 M76541 5.8
CD27 M26842 5.9
NF-X1 U15306 3.3
MTA1-like 1 AB016591 6.2
ALARS D32050 4.0
Mitochondrial Ion protease homolog precursor X74215 21.3
hTRF2 AF002999 3.1
Normalized Intensity Ratios for Genes Known to Influence HIV Infection after CD3/CD28 Stimulation of Jurkat and Nef-Expressing Jurkat
Maximal Normalized Relative Maximal Normalized Relative Intensity Ratio
Encoded Protein GenBank Accession Number Intensity Ratio (CD3/CD28) (Nef and CD3/CD28)
IRF-2 X15949 2.3 8.4
TAT SF1 U76992 1.4 6.3
U1 SNRNP A X06347 2.8 7.4
IL-16 M90391 17.4 1.1
YY1 M76541 5.2 2.3
scriptional constraints that govern anti-CD3 T cell acti- Induction of the Complete Nef Expression Profile
Requires the Presence of TCR and ZAP-70vation. To establish to what extent the NFAT/NF-B
family of transcription factors participates in formation We elected to use the hallmark Nef expression profile
to investigate the role of key T cell-signaling moleculesof the Nef profile, we treated Nef tet cell lines with cyclo-
sporin A (CsA) during the period of induction with doxy- in its induction. Nef can interact with a number of these
and, in addition, is associated with accumulation of oth-cycline. The concentration of CsA used was within the
range maintained in the blood of liver transplant recipi- ers in lipid rafts. The most proximal T cell-signaling Nef
binding protein described is TCR. In order to defineents receiving CsA. Trypan blue staining revealed no
evidence of toxicity at this dose of CsA. We compared the exact position where Nef might act, we compared
gene profiles obtained when Nef was expressed in cellthe expression profiles obtained at 36 hr postinduction
(representative of 24 hr post-Nef expression). CsA treat- lines lacking functional TCR (RT3 Jurkat) and geneti-
cally deficient in ZAP-70 (p116). Nef tet-inducible RT3ment led to a marked suppression of the Nef expression
profile (Figure 4 and Supplemental Figure S2). In the and p116 cell lines were constructed by cotransfection
of tet transactivator and operator plasmids containingpresence of CsA, only 49% of Nef-induced genes were
upregulated. CsA inhibits induction of CIITA (Charreau nef. Stable cell lines were selected on the basis of high
inducible expression with minimal background leak (Fig-et al., 2000), and this was inhibited in our analysis. CsA
does not affect T cell activation upregulation of CDK4 ure 5A). Induction of Nef expression in both RT3 and
p116 resulted in an attenuation of Nef’s transcriptional(Modiano et al., 1994), and this was induced as ex-
pected. No new genes were upregulated following CsA response, which was most marked in cell line RT3 (Fig-
ures 5B and 6). We analyzed the transcripts that weretreatment of Nef-expressing cells. For full documenta-
tion of the effect of CsA on Nef-induced genes, see upregulated more than 3-fold in each cell line. Absence
of TCR resulted in a loss of 52% of Nef-induced genes,supplemental data. The in vitro growth advantage of
Nef-positive HIV virus can be inhibited by cyclosporin while, in the absence of ZAP-70, 44% of Nef-induced
genes were not upregulated. (The supplemental data(Aiken, 1998). It was interesting to note that CsA inhibited
the Nef-mediated induction of several factors that could contains gene lists of those Nef-induced genes that
were prevented from induction in the absence of TCRenhance viral productivity. These included CDK9, Tat-
SF1, NFATc, NF-B, IRF2, c-abl, ATF-2, CIITA, and and ZAP-70). An 89% overlap was observed between
genes repressed in the absence of TCR and those re-GAPB-. The 49% gene repression occurring in the
presence of CsA indicates that a substantial portion of pressed in the absence of ZAP-70. The Nef-TCR inter-
action may contribute to Nef virulence enhancement, asNef T cell signaling is transmitted via the NFAT/NF-B
family and that Nef orchestrates formation of the expres- several genes that are associated with increased viral
productivity are not induced in its absence, includingsion profile above calcineurin in the T cell signaling path.
Immunity
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Figure 4. The Nef Expression Profile Is Suppressed by Cyclosporin A
Nef tet cell lines were treated with cyclosporin at 200 ng/ml and were induced with doxycycline. The ordered list indicates genes unaffected
in induction or partially and completely inhibited in induction in the presence of CsA. We define genes as unaffected by CsA if their expression
ratio differs by less than 30% from the ratio obtained in untreated cells. Genes in which the expression ratio is reduced by more than 70%
are defined as fully repressed, and genes in which the expression ratio is decreased by more than 30% but less than 70% are defined as
partially repressed.
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Figure 5. Formation of the Nef Expression Profile Requires ZAP-70 and TCR
(A) Nef tet-inducible cell lines were created in p116 and RT3 Jurkat cell lines by cotransfecting each cell line with plasmids containing the tet
transactivator element, the tet operator sequence and nef bicistronic with EGFP and a hygromycin resistance cassette. Western blots of Nef
expression after treatment of these cell lines with doxycycline for 12 and 36 hr are shown.
(B) Scatter plots demonstrate differences in gene induction after nef is expressed in RT3 or p116.
c-myb, NFATc, IRF2, CDK9, TAT SF1, TARBP, U1 of P-TEFb, that acts in concert with Tat to facilitate
processive transcription by phosphorylating the CTD ofSNRNP, and c-abl. Therefore, formation of the complete
Nef transcriptional program requires TCR and ZAP-70. RNA pol II. Nuclear extracts depleted of CDK9 lose the
ability to stimulate processive transcription (ManceboIn addition, it is initiated at the highest level in the T cell
signaling path. et al., 1997; Zhu et al., 1997). In addition, the purine
nucleoside analog 5,6-dichloro-1--D-ribofuranosyl-
benzimidazole (DRB), which specifically inhibits CDK9,Nef Induces CDK9 Kinase Activity
Nef-mediated induction of CDK9 mRNA was observed can effectively terminate Tat transcriptional activity
(Marciniak and Sharp, 1991; Zhou et al., 2000). CDK9by our microarray analysis. CDK9 is a key component
Immunity
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Figure 6. Overlap between Gene Repression Occuring after Nef Is Expressed in RT3 or p116 Jurkat
Ordered list showing genes inhibited in induction in the absence of both TCR and ZAP-70, TCR or ZAP-70 alone, and genes unaffected.
Gene inhibition is defined by a normalized relative expression ratio reduced by more than 30% of the value obtained after Nef expression in
Jurkat at 36 hr. These are data obtained from Array 1.2 III alone. Gene lists documenting those factors repressed in induction following Nef
expression in RT3 and p116 are provided in the supplemental data.
mRNA and CDK9 catalytic activity are induced in acti- gated the effect of Nef-mediated CDK9 upregulation on
the efficiency of HIV-1 transcription directed by Tat.vated primary T lymphocytes (Yang et al., 1997; Herr-
mann et al., 1998). We find that Nef expression in Jurkat Jurkat stably transfected with Tat were transiently trans-
fected with either an HIV-1 LTR luciferase reporter orcan induce CDK9 protein (Figure 7B) and kinase activity
(Figure 7C) in addition to mRNA (Figure 7A). We investi- HIV-1 LTR luciferase and Nef. HIV-1 LTR activity in the
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Figure 7. The Nef Expression Profile Pro-
vides a Pointer to Virulence Mechanisms
(A) Northern blot showing CDK9 mRNA induc-
tion after transfection of Jurkat with PI2 or
PI2-WT (WT) vectors.
(B) Western blot of nuclear lysates, showing
induction of CDK9 protein after transfection
with PI2 or WT.
(C) CDK9 in vitro kinase assay of Jurkat trans-
fected with PI2 or WT, using CTD peptide as
substrate. The presence or absence of CTD
substrate is indicated above each lane. Hypo-
phosphorylated (CTDA) and hyperphosphory-
lated (CTDO) forms of CTD peptide are indi-
cated.
(D) Jurkat cells stably transfected with tat (JT
Tat III) were cotransfected with an HIV-1 LTR
luciferase reporter together with pRL-TK as
an internal control and either PI2 or WT. Cells
were left untreated or treated with 10 or 20
M DRB for 6 hr prior to analysis of luciferase
activity. Results are representative of three
experiments.
presence of Nef and Tat was hyperinduced in compari- ment. This overlap is greater in ZAP-70 negative cells
son with the activity observed in the presence of Tat at 61%.
alone (Figure 7D). To establish the contribution of Nef- A central goal of our study was the identification of
mediated induction of CDK9 to this effect, we treated physiologically relevant targets of the Nef transduction
cotransfected cells with 10 or 20 M DRB, which re- pathway. In this way, many of the genes induced by
sulted in a dose-dependent reduction in LTR luciferase Nef provide pointers for unravelling individual virulence
activity. Induction of CDK9 may be a significant aspect mechanisms. HIV-1 proviral gene expression is tightly
of the mechanism by which Nef enhances viral pro- regulated by the binding of host cell proteins to a variety
duction. of cis-acting DNA sequences located within the LTR.
We identified 15 transcription factors upregulated by Nef
that transactivate the LTR. Seven of these are induciblyDiscussion
expressed on T cell activation. T cell-inducible transcrip-
tion factors demonstrate a threshold level of activity thatIn the present study, we have characterized Nef-induced
is concentration dependent (Fiering et al., 1990). Theactivation of T cells in terms of the resulting transcrip-
subversion of the T cell activation path to induce thesetional response. Comparison of the Nef expression pro-
genes is likely to represent an important mechanismfile with that obtained after T cell activation through CD3
facilitating increased virion production. Expression pro-has revealed strong identity but also a small number
filing allows formation of new hypotheses regarding theof important differences. Treatment of Nef-expressing
function of Nef. Induction of Tat-interacting proteinscells with the calcineurin inhibitor CsA prevents upregu-
suggests a role for Nef in the indirect regulation of thelation of 49% of Nef-induced transcripts. Comparison
activity of other HIV accessory genes. Tat is expressedof the hallmark Nef profile with that produced in TCR-
at relatively low levels in HIV-infected cells and requiresand ZAP-70-deficient T cells reveals a key requirement
the presence of additional factors to effectively directfor these in the formation of the full Nef transcriptional
processive transcription. Upregulation of CDK9 is im-response and place Nef as acting high in the T cell
portant, as failure of transcriptional elongation occurssignaling path. Considerable overlap between repressed
in its absence (Mancebo et al., 1997; Zhu et al., 1997).genes occurs after treatment with CsA or expression of
It is conceivable that, among the other genes that areNef in TCR- and ZAP-70-negative Jurkat. Of the 44% of
differentially regulated by Nef, there may be some thatgenes repressed in the Nef-ZAP-70 expression profile,
have as yet undescribed effects on the viral life cycle.89% of these are also absent from the Nef-TCR profile.
The mode of Nef T cell activation may allow a replica-Expression of Nef in TCR-negative T cells generates
56% overlap between genes repressed after CsA treat- tive advantage for the virus, over and above a conven-
Immunity
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Experimental Procedurestional activation stimulus. It was notable that, within
upregulated transcripts, particular to either the Nef or
Plasmids, Tetracycline-Inducible Cell Lines,anti-CD3 activation profile, there was a relative overre-
and Microarray Analysis
presentation of genes that influence HIV replication. A A full description of plasmids, tet cell lines, cell culture, stimulation,
recent study comparing expression profiles obtained drug treatment, RNA isolation, microarray hybridization, analysis,
and statistical methods is provided in the supplemental data.after ligation of platelet-derived growth factor  receptor
and its mutants revealed induction of broadly overlap-
ping gene sets, with only a 2% difference between early Cell Lines, DNA Transfections, and Inhibition Assays
The cell lines Jurkat E6-1 and J.RT3 were obtained from the Ameri-induced genes (Fambrough et al., 1999). It is possible
can Type Culture Collection (ATCC). p116 ZAP-70 and Syk-negativethat small differences between gene expression profiles
Jurkat were kindly provided by Dr. R. Abraham (Duke University).reflect a high degree of specificity in mode of activation
The cell line Jurkat Tat III (Rosen et al., 1986) stably transfected
and influence cellular outcome. The Nef expression pro- with HIV III B Tat was obtained from the United Nations Programme
file provides a molecular explanation for the observa- of HIV/AIDS (UNAIDS) repository, provided by Dr. C.A. Rosen. Tran-
sient transfections were performed by electroporation. Drug inhibi-tions of anti-CD3 hyperreactivity of Nef transgenic thy-
tion assays used cyclosporin A obtained from Sigma and DRB ob-mocytes (Hanna et al., 1998) and Nef-transfected T cells
tained from Calbiochem.(Schrager and Marsh, 1999; Wang et al., 2000). This form
of priming results in hyperinduction of T cell-inducible
Luciferase Assaysgenes after full exogenous activation and is likely to
The HIV-1 LTR luciferase construct pBlue3LTR-luc was obtainedpresent a platform for heightened viral production.
through the AIDS Research and Reference Reagent Program, Divi-
The exact molecular interaction that enables Nef to sion of AIDS, National Institute of Allergy and Infectious Diseases
generate an expression profile akin to that of anti-CD3 (NIAID), National Institutes of Health (NIH) from Dr. Reink Jeeninga
and Dr. Ben Berkhout (Jeeninga et al., 2000). pLTR-luc, pRL-TKT cell activation is unclear. Adaptor molecules can
(Promega), and either PI2 or PI2-WT were electroporated into Jurkatstrongly influence T cell activation thresholds and lead
III Tat cells. In all experiments, transfections were performed into autoimmunity or clonal anergy. It is possible that Nef
triplicate. Drug treatment with 10 or 20 M DRB was performed on
inhibits the function of a constitutive negative regulator, a single pool of transfected cells. The Luciferase Assay system
such as a phosphatase, or an immune adaptor, such as (Promega) was used to assay for luciferase activity at 36 hr post-
cbl-b (Krawczyk et al., 2000). Alternatively, Nef might transfection. Transfection efficiency was normalized using the co-
transfected Renilla luciferase activity.directly recruit T cell signaling molecules to rafts or pre-
cipitate raft clustering. However, Nef is atypical to most
Northern and Western Blot Analysis and Kinase Assaysimmune adaptors, as, although it contains an SH3 bind-
Poly(A) RNA was prepared from Jurkat transfected with PI2-WT anding domain, it is not known to possess SH2, SH3, pleck-
control plasmids. RNA was electrophoresed through a 1% agarosestrin homology, or phosphotyrosine binding domains
formaldehyde gel and transferred to nylon membranes. [-32P]dCTP
that might mediate conventional adaptor protein-protein labeled cDNAs for CDK9 and-actin were prepared using Rediprime
interactions. Preliminary analysis of the expression pro- II from Amersham. Primer sequences used to prepare a 268 bp
file generated by an SH3 binding domain Nef mutant CDK9 cDNA fragment are available from Clontech. For Nef Western
blots, cells were lysed with NP40 lysis buffer, and whole-cell lysateshas revealed that, while this domain contributes to the
were electrophoresed on 12.5% SDS gels. Western blot was per-formation of the profile, it by no means attenuates the
formed with anti-Nef antibody obtained from the UNAIDS repository,full response, suggesting that other modular domains
supplied by Dr. M. Harris. Anti--actin antibody (clone A15) was
of Nef may be involved (our unpublished data). In T cells, obtained from Sigma. For CDK9 Western blot and kinase assays,
the initial signaling event following ligation of the antigen cell lysates were prepared 36 hr posttransfection with Nef or control
expression plasmids. Cells (1 	 107) were pelleted and washed inreceptor is the activation of Src family tyrosine kinases
ice-cold PBS. Lysis buffer containing NP40 was added, and cellsand the subsequent phosphorylation of ITAM motifs in
were left 5 min on ice. The lysate was spun and the pellet washedthe TCR cytoplasmic tail, resulting in the recruitment
once with Tris buffer. Pellets were then disrupted by passing ten
of ZAP-70. Our results provide genetic evidence for a times through a 26 gauge, 0.375 inch injection needle and cleared
requirement for TCR and ZAP-70 in the generation of at 14,000 	 g for 40 min. After electrophoresis on 12.5% SDS gels,
Western blot was performed with anti-CDK9 antibody (Santa Cruz).the Nef transcriptome. Elucidating how Nef usurps the
For kinase assays, CDK9 was immunoprecipitated using anti-CDK9activation path above the level of TCR may provide
antibody, and in vitro kinase assays were performed as describedinformation about the initial events occurring after anti-
by Herrmann et al. (1995). Beads were incubated for 30 min at room
gen receptor triggering. temperature in kinase buffer in the presence or absence of CTD
Our study focused on the target genes of one Nef peptide as substrate. Proteins were blotted to nitrocellulose membranes
variant from HIV-1, SF2. SF2 is an example of a T tropic after electrophoresis on tricene gels (for in vitro kinase assay [IVKA]).
isolate of HIV that is commonly present in late-stage
disease. The mode of T cell activation and the expres- Acknowledgments
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